In the BioHarmony Drug Report Database

"Preview" Icon

Ibuprofen

Advil, Advil Liqui-gels, Advil Migraine Liqui-gels, Caldolor, Children’s Advil, Children’s Advil-flavored, Children’s Elixsure, Children’s Motrin, Ibu, Infant’s Advil, Junior Strength Advil, Junior Strength Motrin, Midol Liquid Gels, Motrin, Motrin Ib, Motrin Migraine Pain, Nuprin, Pediatric Advil, Rufen, Pedea (ibuprofen) is a small molecule pharmaceutical. Ibuprofen was first approved as Advil on 1982-01-01. It is used to treat ankylosing spondylitis, bursitis, dysmenorrhea, fever, and gout amongst others in the USA. It has been approved in Europe to treat patent ductus arteriosus. The pharmaceutical is active against prostaglandin G/H synthase 1 and prostaglandin G/H synthase 2. In addition, it is known to target sodium-coupled monocarboxylate transporter 1, acid-sensing ion channel 1, peroxisome proliferator-activated receptor gamma, and aldo-keto reductase family 1 member C2. Advil’s patents are valid until 2032-03-16 (FDA).

 

Trade Name

 

Pedea
 

Common Name

 

ibuprofen
 

ChEMBL ID

 

CHEMBL521
 

Indication

 

ankylosing spondylitis, bursitis, dysmenorrhea, fever, gout, inflammation, juvenile arthritis, menorrhagia, osteoarthritis, patent ductus arteriosus, postoperative pain, premenstrual syndrome, rheumatoid arthritis
 

Drug Class

 

Anti-inflammatory/analgesic agents (ibuprofen type)

Image (chem structure or protein)

Ibuprofen structure rendering